Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces that a ...
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said on Tuesday a late-breaking poster on its Phase 2a study of intranasal foralumab ...
Acute myeloid leukemia (AML) has a poor prognosis, especially in elderly and relapsed/refractory patients, with 5‑year ...
Morning Overview on MSN
Nasal spray shows signs of reversing brain aging markers in early study
Two squirts of a nasal spray made from stem-cell particles dialed back inflammatory markers of brain aging in middle-aged ...
I initiate coverage on Forte Biosciences stock at a 'Hold' rating due to both pipeline risk and upcoming clinical catalysts.
Cartesian Therapeutics, Inc. (RNAC) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 9:30 AM EDTCompany ParticipantsCarsten Brunn ...
Alzheimer’s isn’t just one problem—it’s a tangled mix of biology, aging, and overall health. That’s why drugs targeting a single factor have fallen short, even as new treatments show modest benefits.
Celiac disease, a common autoimmune condition affecting approximately 1% of the population, can develop with exposure to gluten at any age. Diagnosis involves serologic testing, especially for IgA ...
Exzavier Whitley Announces Genre-Expanding R&B Album “No Boundaries" NEW YORK, NY, UNITED STATES, April 10, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results